Viewing Study NCT00747695


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2026-01-02 @ 10:12 AM
Study NCT ID: NCT00747695
Status: COMPLETED
Last Update Posted: 2011-01-10
First Post: 2008-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module